RICHARD W KRAMP
CIK 936971 · President and CEO · last filed 2023-08-07
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$24.7K
Companies
4
Total Filings
26
Lifetime Open-Market Net
-$551.8K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NVEC | Director | 225 | $109.88 | $24.7K | $0 | 10 | 2023-08-07 |
| VASCULAR SOLUTIONS INC (VASC) Delisted | Director | 9,910 | — | — | $34.9K | 5 | 2017-02-09 |
| ROCHESTER MEDICAL CORPORATION (ROCM) Delisted | Director | 12,281 | — | — | $0 | 1 | 2013-02-04 |
| SYNOVIS LIFE TECHNOLOGIES INC (SYNO) Delisted | President and CEO | 66,698 | — | — | -$586.7K | 8 | 2011-05-27 |
Recent Filings · Page 2 of 3
26 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2016-08-05 | NVEC | Grant (A) | — | $0 | EDGAR |
| 2016-05-03 | VASCULAR SOLUTIONS INC (VASC) Delisted | Mixed | +1,427 | -$25.1K | EDGAR |
| 2015-08-07 | NVEC | Grant (A) | — | $0 | EDGAR |
| 2015-05-04 | VASCULAR SOLUTIONS INC (VASC) Delisted | Mixed | +1,229 | -$34.3K | EDGAR |
| 2014-11-14 | VASCULAR SOLUTIONS INC (VASC) Delisted | Buy (P) | +1,475 | $34.9K | EDGAR |
| 2013-11-18 | — | Disp (D) | −12,281 | -$245.6K | |
| 2013-05-07 | VASCULAR SOLUTIONS INC (VASC) Delisted | Grant (A) | +4,687 | $0 | EDGAR |
| 2013-02-04 | ROCHESTER MEDICAL CORPORATION (ROCM) Delisted | Grant (A) | +12,281 | $0 | EDGAR |
| 2011-05-27 | SYNOVIS LIFE TECHNOLOGIES INC (SYNO) Delisted | Exer (M) | +75,000 | $562.5K | EDGAR |
| 2011-04-05 | SYNOVIS LIFE TECHNOLOGIES INC (SYNO) Delisted | Sell (S) | −4,265 | -$83.4K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.